Search

everythinglearnresearchcommunity

for

Search:↓

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

A woman's high testosterone levels were caused by a rare ovarian tumor, not the initially diagnosed condition.

Proximal hair cortisol is a reliable tool for diagnosing Cushing's Syndrome.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Copeptin and cortisol levels are higher in alopecia areata patients, suggesting they could help diagnose and manage the condition.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

CRH causes hair loss by reducing autophagy and increasing cell death in hair cells.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

5α-reduced neurosteroids may help regulate glial cell differentiation.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Check hormone levels in older women to find hidden conditions like certain tumors.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Blood pressure medications may increase the risk of skin cancer.

Adenosine treatment thickens hair in Caucasian men with hair loss.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

Prairie dogs with fewer neighbors are more stressed but their number of babies isn't affected.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

A woman with a rare hair loss condition developed skin cancer in the bald area.

Cyclosporine improved skin condition in dogs with sebaceous adenitis.